NEW YORK (GenomeWeb News) – Compugen said today that it raised net proceeds of $19 million through a previously announced equity offering.

As part of the offering, which was established in late October with Cantor Fitzgerald, Compugen sold approximately 4.1 million shares at a weighted average price of approximately $4.91 per share, resulting in $20 million in gross proceeds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.